DOCETAXEL
- Product NDC
- 50742-431
- 11-digit product format
- 507420431
- Labeler code
- 50742
- Product ID
- 50742-431_4e07912c-8e9d-41c3-9408-d2e5dd9d5e7e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DOCETAXEL ANHYDROUS
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Ingenus Pharmaceuticals, LLC
- Application
- ANDA207563
- Marketing category
- ANDA
- Marketing start
- 2017-09-07
- Marketing end
- 0000-00-00
- Substance
- DOCETAXEL ANHYDROUS
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50742-431 | DOCETAXEL (DOCETAXEL ANHYDROUS) INJECTION, SOLUTION [INGENUS PHARMACEUTICALS, LLC] | 13 | Legacy NDC | 20240201_b17679e8-88c8-4b8d-bfae-246fab6eead9.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50742-431-08 | 50742043108 | 1 VIAL, MULTI-DOSE in 1 CARTON (50742-431-08) > 8 mL in 1 VIAL, MULTI-DOSE | 2017-09-07 | 0000-00-00 | No | No | Current |